Placebo
Placebo is an intervention with 41,384 clinical trials. Currently 4,822 active trials ongoing. Historical success rate of 87.4%.
Success Metrics
Based on 26,597 completed trials
Phase Distribution
Phase Distribution
8664
Early Stage
12800
Mid Stage
13004
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.7%
26597 of 31791 finished
16.3%
5194 ended early
4822
trials recruiting
41,384
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
Clinical Trials (41,384)
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial
A Study to Test Whether BI 1356225 Improves Impulsive Behavior in People With Opioid Use Disorder Who Are Taking Buprenorphine
Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 41,384